« Entradas por tag: amore
15 de Junio, 2010
· General |
|
With the very-recent FDA approval of Amgen's Prolia®, this dropout rate (or "switch-over" rate, if one prefers) is very likely to rise in the U.S. Note that 61 percent of patients go off of Fosamax® (or its generic equivalent, alendronate) within a year, according to a just released SDI analysis.
This really is the hard winter's freeze setting in, on Fosamax:
. . . .Currently, alendronate, sometimes filled as Fosamax but more frequently as the generic equivalent, is the most popular treatment... Continuar leyendo |
|
publicado por
glopytere a las 09:04 · 2 Comentarios
· Recomendar |
|
|
Calendario |
|
Mayo 2024 |
|
|
DO | LU | MA | MI | JU | VI | SA | | | | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 |
|
|
| |
|